MétaCan
Menu
Back to cohort
Record W4295988800 · doi:10.1016/j.xgen.2022.100169

A patient-driven clinicogenomic partnership for metastatic prostate cancer

2022· article· en· W4295988800 on OpenAlexaboutno aff
Jett Crowdis, Sara Balch, Lauren Sterlin, Beena Thomas, Sabrina Y. Camp, Michael Dunphy, Elana Anastasio, Shahrayz Shah, Alyssa L. Damon, Rafael Ramos, Delia Sosa, Ilan K. Small, Brett N. Tomson, Colleen M. Nguyen, Mary McGillicuddy, Parker Chastain, Meng Xiao He, Alexander T. M. Cheung, Stephanie A. Wankowicz, Alok K. Tewari, Dewey Kim, Saud H. AlDubayan, Ayanah Dowdye, Benjamin Zola, Joel Nowak, Jan Manarite, Idola Henry Gunn, Bryce T. Olson, Eric S. Lander, Corrie Painter, Nikhil Wagle, Eliezer M. Van Allen

Bibliographic record

VenueCell Genomics · 2022
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Treatment and Research
Canadian institutionsnot available
FundersNational Institute of General Medical SciencesNational Cancer InstituteGenentechPuma BiotechnologyU.S. Department of DefenseBroad InstituteProstate Cancer FoundationMovember FoundationAmerican Society of Clinical OncologyNational Institutes of HealthNational Science FoundationConquer Cancer FoundationRoche
KeywordsGeneral partnershipProstate cancerEconomic shortageMedicineLung cancerExome sequencingExomeOncologyInternal medicineCancerBiologyPolitical scienceGene

Abstract

fetched live from OpenAlex

Molecular profiling studies have enabled discoveries for metastatic prostate cancer (MPC) but have predominantly occurred in academic medical institutions and involved non-representative patient populations. We established the Metastatic Prostate Cancer Project (MPCproject, mpcproject.org), a patient-partnered initiative to involve patients with MPC living anywhere in the US and Canada in molecular research. Here, we present results from our partnership with the first 706 MPCproject participants. While 41% of patient partners live in rural, physician-shortage, or medically underserved areas, the MPCproject has not yet achieved racial diversity, a disparity that demands new initiatives detailed herein. Among molecular data from 333 patient partners (572 samples), exome sequencing of 63 tumor and 19 cell-free DNA (cfDNA) samples recapitulated known findings in MPC, while inexpensive ultra-low-coverage sequencing of 318 cfDNA samples revealed clinically relevant AR amplifications. This study illustrates the power of a growing, longitudinal partnership with patients to generate a more representative understanding of MPC.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.008
metaresearch head score (Gemma)0.011
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.012
Threshold uncertainty score0.040

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0080.011
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0030.001
Scholarly communication0.0020.001
Open science0.0010.006
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0120.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.070
GPT teacher head0.352
Teacher spread0.282 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations10
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueCell GenomicsSame topicProstate Cancer Treatment and ResearchFrench-language works237,207